These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16436456)

  • 21. Cowden syndrome-associated germline succinate dehydrogenase complex subunit D (SDHD) variants cause PTEN-mediated down-regulation of autophagy in thyroid cancer cells.
    Yu W; Ni Y; Saji M; Ringel MD; Jaini R; Eng C
    Hum Mol Genet; 2017 Apr; 26(7):1365-1375. PubMed ID: 28164237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN: one gene, many syndromes.
    Eng C
    Hum Mutat; 2003 Sep; 22(3):183-98. PubMed ID: 12938083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of cryptic splicing in germline PTEN intronic variants in Cowden syndrome.
    Chen HJ; Romigh T; Sesock K; Eng C
    Hum Mutat; 2017 Oct; 38(10):1372-1377. PubMed ID: 28677221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cowden syndrome: report of two cases with immunohistochemical analysis for PTEN expression.
    Zabetian S; Mehregan D
    Am J Dermatopathol; 2012 Aug; 34(6):632-4. PubMed ID: 22481496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations.
    Ngeow J; Mester J; Rybicki LA; Ni Y; Milas M; Eng C
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E2063-71. PubMed ID: 21956414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Male breast cancer in Cowden syndrome patients with germline PTEN mutations.
    Fackenthal JD; Marsh DJ; Richardson AL; Cummings SA; Eng C; Robinson BG; Olopade OI
    J Med Genet; 2001 Mar; 38(3):159-64. PubMed ID: 11238682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utilizing PTEN immunohistochemistry as a screening test for Cowden syndrome.
    Hartsough E; DeSimone MS; Lorenzo ME; Dias-Santagata D; Nose V; Hoang MP
    Am J Clin Pathol; 2024 May; 161(5):490-500. PubMed ID: 38206110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cowden syndrome-associated germline SDHD variants alter PTEN nuclear translocation through SRC-induced PTEN oxidation.
    Yu W; He X; Ni Y; Ngeow J; Eng C
    Hum Mol Genet; 2015 Jan; 24(1):142-53. PubMed ID: 25149476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.
    Banneau G; Guedj M; MacGrogan G; de Mascarel I; Velasco V; Schiappa R; Bonadona V; David A; Dugast C; Gilbert-Dussardier B; Ingster O; Vabres P; Caux F; de Reynies A; Iggo R; Sevenet N; Bonnet F; Longy M
    Breast Cancer Res; 2010; 12(4):R63. PubMed ID: 20712882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Germline
    Lopez C; Abuel-Haija M; Pena L; Coppola D
    Cancer Genomics Proteomics; 2018; 15(2):115-120. PubMed ID: 29496690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline alterations in RASAL1 in Cowden syndrome patients presenting with follicular thyroid cancer and in individuals with apparently sporadic epithelial thyroid cancer.
    Ngeow J; Ni Y; Tohme R; Song Chen F; Bebek G; Eng C
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1316-21. PubMed ID: 24712574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case Report.
    Neychev V; Sadowski SM; Zhu J; Allgaeuer M; Kilian K; Meltzer P; Kebebew E
    J Clin Endocrinol Metab; 2016 Feb; 101(2):353-8. PubMed ID: 26678657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline PTEN Mutation Analysis for PTEN Hamartoma Tumor Syndrome.
    Ngeow J; Eng C
    Methods Mol Biol; 2016; 1388():63-73. PubMed ID: 27033071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a Cowden syndrome patient with a novel PTEN mutation and establishment of patient-derived induced pluripotent stem cells.
    Obayashi F; Hamada A; Yamasaki S; Kanda T; Toratani S; Okamoto T
    In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):69-78. PubMed ID: 34984555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cowden syndrome.
    Gustafson S; Zbuk KM; Scacheri C; Eng C
    Semin Oncol; 2007 Oct; 34(5):428-34. PubMed ID: 17920899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different splicing defects lead to differential effects downstream of the lipid and protein phosphatase activities of PTEN.
    Agrawal S; Pilarski R; Eng C
    Hum Mol Genet; 2005 Aug; 14(16):2459-68. PubMed ID: 16014636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
    Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
    Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The tumor suppressor PTEN interacts with p53 in hereditary cancer (Review).
    Nakanishi A; Kitagishi Y; Ogura Y; Matsuda S
    Int J Oncol; 2014 Jun; 44(6):1813-9. PubMed ID: 24718924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes.
    Orloff MS; He X; Peterson C; Chen F; Chen JL; Mester JL; Eng C
    Am J Hum Genet; 2013 Jan; 92(1):76-80. PubMed ID: 23246288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple colon carcinomas in a patient with Cowden syndrome.
    Bosserhoff AK; Grussendorf-Conen EI; Rübben A; Rudnik-Schöneborn S; Zerres K; Buettner R; Merkelbach-Bruse S
    Int J Mol Med; 2006 Oct; 18(4):643-7. PubMed ID: 16964417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.